Format: Live Webinar
Credit:  1.0 AMA PRA Category 1
Credit:  1.0 ARRT Category A+
Fee for Credit Certificate: $0
 

Breast MRI Case Review
Interesting Cases and Future Applications

A certified one-hour program for medical imaging and healthcare professionals including radiologists, interventional radiologists, advanced-level radiologic technologists, and other healthcare providers who treat patients with breast disease.

Wednesday • June 27, 2012
7:00 pm EASTERN / 6:00 pm CENTRAL / 5:00 pm MOUNTAIN / 4:00 pm PACIFIC
 

Click the ENROLL NOW icon to the left to register.

Course Overview

In the United States, breast cancer is the most common non-skin cancer and the second leading cause of cancer-related death in women.[1] Early detection and treatment can often mean the difference between life and death.

Based on recent evidence on the efficacy of breast magnetic resonance imaging (MRI) screening in high-risk patients, the American Cancer Society (ACS) has issued guidelines for the early detection of breast cancer that include MRI.[2] Additionally, MRI is emerging as an important tool in the treatment of breast cancer patients to evaluate the extent of disease, assess tumor response to neoadjuvant chemotherapy, and for preoperative planning.

This series brings to learners the opportunity to view a variety of breast MRI cases as expert faculty share their experience and approach to breast MRI in their practice.

[1] Source for incidence and mortality data: Surveillance, Epidemiology, and End Results (SEER) Program and the National Center for Health Statistics.  Available at http://seer.cancer.gov
[]2] Saslow D, Boetes C, Burke W, Harms S, Leach MO, Lehman CD, et al. American Cancer Society Breast Cancer Advisory Group. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin. 2007;57:75-89.


Educational Objectives for the Series

At the conclusion of this activity, participants should be better able to:

• Develop a systematic strategy to interpret breast MR images and improve diagnostic accuracy
• Use standardized terminology to assess and report breast MRI abnormalities in accordance with ACR BI-RADS® for MRI
• Evaluate the role of morphology and kinetics when assessing a breast lesion
• Apply standard methods and strategies for MRI-guided breast biopsy intervention

Accreditation & Credit

Credit CANNOT be granted for group viewing.  To receive credit, EACH attendee must sign in on a separate computer.

Physicians
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Postgraduate Institute for Medicine and International Center for Postgraduate Medical Education. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The Postgraduate Institute for Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 

Radiologic Technologists
This program has been approved by the American Society of Radiologic Technologists (ASRT) for 1.0 hour of ARRT Category A+ continuing education credit.


How to Participate

This program is offered by ICPME through WebEx webinar service.

• Click ENROLL NOW and follow the registration instructions to register with ICPME.
• You will receive an email from ICPME confirming your registration.
• At the end of the registration process, click on ACCESS WEBINAR to enroll with WebEx and complete the pre-course evaluation.
• Log-in instructions for the day of the webinar will be sent to you via e-mail upon completion of the precourse evaluation.

Please note: The WebEx platform will play on desktop or laptop computers only. It will not play on mobile devices.

To Apply for Credit

There are no fees to participate in this activity. Each participant will need a computer with internet access.

• To receive credit, each participant must register, complete the precourse evaluation, attend the entire educational activity, and complete the postcourse evaluation at the end of the session. Credit cannot be granted for group viewing.
• Upon verification of your participation, you will receive an email with instructions to print your certificate from your online account at www.icpme.us.

Faculty Biography

Gary M. Levine, MD
Associate Clinical Professor
Keck School of Medicine of USC
Medical Director of Breast Imaging
Hoag Breast Care Center

Dr. Levine received his undergraduate degree from Tufts University and his medical degree from Albany Medical College. After completing his residency in Diagnostic Radiology at the University of California, Irvine and becoming board certified in diagnostic radiology in 1992, Dr. Levine went on to specialized fellowship training in breast imaging in Sweden under renowned mammographer Dr. Laszlo Tabar.

Dr. Levine is the Director of Breast Imaging at Hoag Breast Care Center in Newport Beach, CA and is an Associate Clinical Professor of Radiology at USC Keck School of Medicine. Presently Dr. Levine serves on the Board of Trustees and is President-Elect of the National Consortium of Breast Centers.  He also serves on the Steering Committee of the American Society of Clinical Oncology (ASCO) – Breast Program.

Dr. Levine has lectured nationally and internationally and has authored numerous peer- reviewed journal articles and book chapters and regularly appears in the media as a medical expert in the field of breast cancer. In 2007, he was named one of the top 25 innovators in healthcare by Health IT magazine. Finally, Dr. Levine is a pioneer in the technique of breast tumor cryoablation.  


Disclosure of Conflicts of Interest

The Postgraduate Institute for Medicine (PIM) assesses conflict of interest with its instructors, planners, managers, and other individuals who are in a position to control the content of CME activities. All relevant conflicts of interest that are identified are thoroughly vetted by PIM for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty has reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Gary M. Levine, MD has received fees for consulting and non-CME/CE services from Hologic, Inc.

The following planners and managers have reported NO financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Sharon Cancino  
Laura Excell, ND, NP, MS, MA, LPC, NCC 
Trace Hutchison, PharmD
Samantha Mattiucci, PharmD                
Victoria Phoenix, BS
Lisa Schleelein, MEd
Patricia Staples, MSN, NP-C, CCRN



Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. PIM, ICPME and Hologic, Inc., do not recommend the use of any agent outside of the labeled indications. 

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of PIM, ICPME and Hologic, Inc. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


Questions

For questions regarding this program, please contact ICPME:
Email: information@icpmed.com
Phone: 607-257-5860 x10



Jointly Sponsored by

               
 




This activity is supported by an educational grant from




Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.